Gene · 156
Papers3,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Can pyroptosis be a new target in rheumatoid arthritis treatment? | Front Immunol | 2023 | 37426634 | PubTator, text mining | PubMed |
| Association between the triglyceride-glucose index and the risk of mortality among patients with chronic heart failure: results from a retrospective cohort study in China. | Cardiovasc Diabetol | 2023 | 37420232 | PubTator, text mining | PubMed |
| Mu-opioid receptor selective superagonists produce prolonged respiratory depression. | iScience | 2023 | 37416459 | PubTator, text mining | PubMed |
| Profiling of basal and ligand-dependent GPCR activities by means of a polyvalent cell-based high-throughput platform. | Nat Commun | 2023 | 37407564 | PubTator, text mining | PubMed |
| Ubiquitination of GRK2 Is Required for the β-Arrestin-Biased Signaling Pathway of Dopamine D2 Receptors to Activate ERK Kinases. | Int J Mol Sci | 2023 | 37373182 | PubTator, text mining | PubMed |
| G Protein-Coupled Receptors and the Rise of Type 2 Diabetes in Children. | Biomedicines | 2023 | 37371671 | PubTator, text mining | PubMed |
| β3 Receptor Signaling in Pregnant Human Myometrium Suggests a Role for β3 Agonists as Tocolytics. | Biomolecules | 2023 | 37371585 | PubTator, text mining | PubMed |
| Synuclein Proteins in Cancer Development and Progression. | Biomolecules | 2023 | 37371560 | PubTator, text mining | PubMed |
| A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells. | Cancers (Basel) | 2023 | 37370829 | PubTator, text mining | PubMed |
| Significance of Endothelial Dysfunction Amelioration for Sodium-Glucose Cotransporter 2 Inhibitor-Induced Improvements in Heart Failure and Chronic Kidney Disease in Diabetic Patients. | Metabolites | 2023 | 37367894 | PubTator, text mining | PubMed |
| Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression. | Respir Res | 2023 | 37344825 | PubTator, text mining | PubMed |
| Investigation of adenosine A1 receptor-mediated β-arrestin 2 recruitment using a split-luciferase assay. | Front Pharmacol | 2023 | 37324481 | PubTator, text mining | PubMed |
| Functional LTCC-β2AR Complex Needs Caveolin-3 and Is Disrupted in Heart Failure. | Circ Res | 2023 | 37313722 | PubTator, text mining | PubMed |
| Multiple p38/JNK mitogen-activated protein kinase (MAPK) signaling pathways mediate salt chemotaxis learning in C. elegans. | G3 (Bethesda) | 2023 | 37310929 | PubTator, text mining | PubMed |
| Myostatin: a potential therapeutic target for metabolic syndrome. | Front Endocrinol (Lausanne) | 2023 | 37288303 | PubTator, text mining | PubMed |
| The role of noncoding genetic variants in cardiomyopathy. | Front Cardiovasc Med | 2023 | 37283586 | PubTator, text mining | PubMed |
| Distinct Role of Lycium barbarum L. Polysaccharides in Oxidative Stress-Related Ocular Diseases. | Pharmaceuticals (Basel) | 2023 | 37259363 | PubTator, text mining | PubMed |
| Mechanistic-Based Classification of Endocytosis-Related Inhibitors: Does It Aid in Assigning Drugs against SARS-CoV-2? | Viruses | 2023 | 37243127 | PubTator, text mining | PubMed |
| Insulin-like Growth Factor-1 (IGF-1) Related Drugs in Pain Management. | Pharmaceuticals (Basel) | 2023 | 37242543 | PubTator, text mining | PubMed |
| Function and Role of Histamine H1 Receptor in the Mammalian Heart. | Pharmaceuticals (Basel) | 2023 | 37242517 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/156/papers?page=12